X0306 4 2020-07-27 0001682852 Moderna, Inc. MRNA 0001690927 Zaks Tal Zvi C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 Chief Medical Officer Common Stock 2020-07-27 4 M 0 10000 20.93 A 10000 D Common Stock 2020-07-27 4 M 0 10000 19.15 A 20000 D Common Stock 2020-07-27 4 S 0 2384 76.79 D 17616 D Common Stock 2020-07-27 4 S 0 3940 77.68 D 13676 D Common Stock 2020-07-27 4 S 0 5548 78.73 D 8128 D Common Stock 2020-07-27 4 S 0 7228 79.72 D 900 D Common Stock 2020-07-27 4 S 0 900 80.43 D 0 D Stock Option (Right to Buy) 20.93 2020-07-27 4 M 0 10000 0 D 2020-03-08 2029-03-08 Common Stock 10000 299195 D Stock Option (Right to Buy) 19.15 2020-07-27 4 M 0 10000 0 D 2026-08-10 Common Stock 10000 204790 D The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.19 to $77.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.20 to $78.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.21 to $79.20. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.22 to $80.20. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.27 to $80.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. This option is fully vested and exercisable. This option is fully vested and exercisable. /s/ Lori Henderson, as Attorney-in-Fact 2020-07-29